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Periplasmic adaptor proteins are essential components of bacterial tripartite multidrug efﬂux
pumps. Here we report the 2.35 Å resolution crystal structure of the BesA adaptor from the spiro-
chete Borrelia burgdorferi solved using selenomethionine derivatized protein. BesA shows the
archetypal linear, ﬂexible, multi-domain architecture evident among proteobacteria and retains
the lipoyl, b-barrel and membrane-proximal domains that interact with the periplasmic domains
of the inner membrane transporter. However, it lacks the a-hairpin domain shown to establish
extensive coiled-coil interactions with the periplasmic entrance helices of the outer membrane-
anchored TolC exit duct. This has implications for the modelling of assembled tripartite efﬂux
pumps.
 2013 The Authors. Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY license.1. Introduction [13,14] efﬂux pump adaptors have revealed conserved ﬂexible,Tripartite efﬂux pumps span the inner and outer membranes of
Gram-negative bacteria to expel antibiotics, metals and other nox-
ious molecules [1–3]. They are key to survival and the development
of multidrug resistance (MDR). Efﬂux substrates bind to an inner
membrane (IM) transporter, typically a proton antiporter (e.g. Esch-
erichia coli AcrB), before delivery to the TolC exit duct [4]. Trimeric
TolC [5], anchored in the outer membrane (OM), projects an a-heli-
cal barrel into the periplasm where it contacts tip-to-tip [6–8] the
70 Å periplasmic extension of the IM trimeric AcrB transporter [9].
Extensive in vivo site-speciﬁc cross-linking and multidomain dock-
ing showed that pump assembly is established and stabilised by
extensive interactions of both IM and OM components with a ubiq-
uitous third component, the periplasmic adaptor protein [7]. Struc-
tural analysis of the Pseudomonas aeruginosa adaptor MexA [7,10]
and subsequently other multidrug resistance [11,12] and metallinearly arranged domains: a membrane proximal (MP) domain, a
b-barrel domain, a lipoyl domain and an a-helical hairpin. The
MP, b-barrel, and lipoyl domains of AcrA contact AcrB while the full
length of the 47 Å long a-hairpin establishes extensive coiled-coil
interactions with the periplasmic entrance of each TolC protomer
[7,15]. The adaptor multidomain structure is conserved throughout
proteobacteria, but primary sequence comparison in the spirochete
Borrelia burgdorferi suggested that a tripartite MDR pump, BesABC,
included an adaptor that appeared to lack an a-hairpin [16]. This
study reported besC, besA and besB are co-transcribed in an operon,
and that insertional disruption of the besCAB operon abrogates
expression of BesC, BesB and BesA and causes up to 64-fold reduc-
tion in theminimal inhibitory concentrations for several antibiotics,
SDS and ethidiumbromide. Bunikis et al. concluded that BesABC is a
functional tripartite RND efﬂux pump. The absence of an adaptor
hairpin in a tripartite pump would be unprecedented and would
have implications for understanding the assembly of MDR efﬂux
pumps [2]. We therefore crystallised the BesA adaptor.
2. Materials and methods
Expression of soluble BesA – The BesA sequence indicated a signal
sequence and lipidation site (Cys 26) comparable to IM-associated
periplasmic adaptors E. coli AcrA and P. aeruginosa MexA, so
besA codons 27–318 from Borrelia burgdorferi B31 genomic DNA
(ATCC 35210) were ampliﬁed with forward and reverse primers
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GCGCGGATC CTTAAATATTGCTTTCGGCTGAAAGACCCTC-30), and
the product digested with NdeI/BamHI and cloned into pET28
(Novagen). The resultant pET28-BesA plasmid encodes BesA in
which the N-terminal signal sequence is replaced with a hexahisti-
dine tag.
For selenomethionine incorporation, E. coli B834 (DE3) was
transformed with pET28-BesA, and grown in M9 minimal medium
containing 50 lg ml1 selenomethionine. At A600 0.6, 0.1 mM IPTG
was added and the culture continued for 16 h at 18 C. Cell pellets
were resuspended in 50 mM HEPES pH 8.0, 400 mM NaCl, 5% glyc-
erol, 10 mM MgCl2. 1 mM TCEP was included in all buffers. Cells
were broken in a cell disruptor (30000 psi) and centrifuged
(150000g, 1 h at 4 C). Supernatant was incubated with IMAC re-
sin (Biorad) and 4 mM imidazole (1 h, 4 C). Resin was washed in
buffer A (25 mM HEPES pH 8.0, 500 mM NaCl, 8 mM imidazole)
containing 0.1% Triton X-100, then buffer A alone. Protein was
eluted in 25 mM HEPES pH 8.0, 200 mM NaCl and 250 mM imidaz-
ole and loaded onto a Superdex S75 column equilibrated in 25 mM
HEPES pH 8.0, 150 mM NaCl and peak fractions concentrated to
10 mg ml1. To produce native BesA, E. coli C41 [17] cells bearing
pET28-BesA were grown in 2xTY medium, with expression and
puriﬁcation as above, except the hexahistidine tag was removed
with thrombin (Novagen) before loading on a Superdex S75 col-
umn. Protein eluted with a molecular weight consistent with
monomeric BesA.
Attempts to express correctly folded and localised BesB using
N- and C-terminal his- and strep-tags as well as fusions with malt-
ose-binding protein and GFP were repeatedly unsuccessful. A con-
struct, in which the region up to and including the BesB N-terminal
transmembrane helix was replaced with the equivalent region of
AcrB, also failed to express. Though small amounts of BesC can
be expressed, we have not been able to crystallise it.
Crystallisation and data collection – BesA crystallisation was con-
ducted using sitting drop vapour diffusion at 15 C. 2 ll protein
solution was mixed with either 1 ll (C2 and P21 crystal forms) or
2 ll (P212121 crystal form) crystallisation reagent and equilibrated
against 500 ll reagent. The P212121 form was crystallised using
100 mM phosphate/citrate pH 4.2, 100 mM LiSO4, 16% PEG 1000.
C2 and P21 forms were obtained using thrombin-treated protein
with crystallization reagents comprising 100 mM phosphate/cit-
rate pH 4.2, 30% PEG 300, and 100 mM citrate pH 4.7, 9% PEG
6000, respectively. Crystals grew to a maximum size of
0.3 mm  0.2 mm  0.2 mm in four days.
Crystals were cryoprotected by stepwise addition of 12 ll cryo-
protectant to the crystallisation drop, before being ﬂash-frozen in
liquid nitrogen. Cryoprotectant for P212121 crystals comprised
100 mM phosphate/citrate pH 4.2, 200 mM LiSO4, 15% PEG 1000
and 25% PEG 400. Cryoprotectants for the native C2 and P21 crystal
forms contained 100 mM phosphate/citrate pH 4.2, 15% PEG 300,
25% glycerol and 100 mM citrate pH 4.2, 12% PEG 6000, 25% glyc-
erol, respectively.
X-ray diffraction data were collected at 100 K on beamline ID29
at the European Synchrotron Radiation Facility (Grenoble, France),
after screening on beamline I02 at Diamond Light Source (Oxford,
UK).
Crystal structure determination and analysis – X-ray data sets
were indexed and integrated using iMosﬂm [18] and scaled using
Scala or Aimless in the CCP4 suite [19]. Crystallographic phases
for the 2.6 Å selenomethionine dataset were obtained by Single-
wavelength anomalous diffraction (SAD). Selenium sites were
identiﬁed using HYSS [20], and phases calculated with Phaser
[21]. Density modiﬁcation was performed in Parrot [22] using 4-
fold non-crystallographic symmetry (NCS) and an initial model of
BesA built with Buccaneer [23] with four monomers in the
asymmetric unit. The structure was completed with manualmodel-building in Coot [24] and reﬁnement in Phenix [25] using
NCS restraints between each of the three BesA domains. Upon
completion of the selenoprotein model, reﬁnement was switched
to the isomorphous high-resolution data, maintaining the same
‘free’ reﬂection list. Model building and reﬁnement employed Coot
[24] and Refmac [26], with NCS restraints as before.
Structures of C2 and P21 crystal forms were determined by
molecular replacement using Molrep [27] or Phaser [21] with a
BesA monomer as a probe. Reﬁnement was performed as above ex-
cept the C2 data initially beneﬁtted from jelly body reﬁnement and
did not make use of NCS restraints. Validation was assisted by Mol-
probity [28] and Procheck [29]. The ﬁnal model of the high resolu-
tion C2 crystal form is the only dataset for which a reasonable
atomic model could be built for the residual loop (i.e. residues
106–114). The structures have been deposited in the PDB with
accession codes 4KKS, 4KKT and 4KKU.
Root mean square deviations (RMSDs) were calculated using
PDBeFold (http://www.ebi.ac.uk/msd-srv/ssm) [30]. Homology
models of BesC and BesB were created using Phyre [31], based on
TolC (1EK9) and AcrB (1T9Y), respectively. Figures were prepared
using PyMol [32].
Molecular dynamics (MD) simulations – Energy minimizations
and MD simulations were performed using Amber11 [33] as
previously [34]. The protein formal charge of +6e was neutralized
by adding Cl ions. The simulated system consists of 276 residues,
6 Cl ions, and 18,589 water molecules, making a total of 60159
atoms. MD trajectory calculations of 23 ns were performed on
the Darwin cluster (http://www.hpc.cam.ac.uk/services/darwin.
html).
3. Results and discussion
The crystal structure of the complete BesA protein was solved
by SAD in three space groups, P212121 (2.35 Å resolution), P21
(2.5 Å) and C2 (2.6 Å) (Table 1), in which either a monomer (C2)
or four intertwined head-to-tail monomers (P21 and P212121,
Fig. 1A) are present in the asymmetric unit. Given the protein is
membrane localised by an N-terminal lipidation, this head-to-tail
arrangement, also seen in the isolated CusB structure [14], cannot
be physiologically relevant. The BesA monomer shows the arche-
typal, multidomain adaptor topology, with the MP, b-barrel, and
lipoyl domains in linear arrangement (coloured orange, yellow
and green, respectively, in Fig. 1A and B). However, the expected
ﬁnal a-hairpin domain is completely absent, conﬁrming what
was predicted from sequence analysis [16], leaving only a nine res-
idue loop (Pro106 to Leu114, blue in Fig. 1B) linking the two halves
of the lipoyl domain. Density for this loop is visible only in the C2
monomer (Fig. 1C) where it is stabilised by the loop of a neighbour-
ing monomer in the crystal lattice, but high B-factors here and
poorly deﬁned density for the P212121 or P21 monomers indicate
the small loop is highly ﬂexible. The BesA architecture is distinct,
the other adaptor structures have a well deﬁned a-helical hairpin
up to 67 Å/90 residues long (Fig. 2) [10–14]. The B. burgdorferi gen-
ome reveals no other adaptors that could perform the function of
BesA, and no hairpin-encoding gene in the vicinity of the besCAB
operon. However we cannot exclude that a novel, unidentiﬁed fac-
tor exists that could compensate for the lack of an a-hairpin in
BesA.
The conservedMP, b-barrel, and lipoyl domains of BesA have low
RMSDs compared to counterparts in other MDR [7,10–12] and hea-
vy metal efﬂux (HME) pump adaptors [13,14] (Supplemental Ta-
ble 1). This conforms to the view they play a key role in pump
assembly and function, particularly in binding to the large periplas-
mic extension of the IM transporters. As would be expected in this
case, primary sequence analysis indicates the cognate interacting
transporter domains of BesB and other transporters are likewise
Table 1
Crystallographic data and reﬁnement statistics.
BesA – SeMet BesA – SeMet BesA – native BesA – native
Data collection
Space group P212121 P212121 P21 C2
Cell dimensions
a, b, c (Å) 73.71, 151.93, 155.46 73.74, 152.13, 155.49 78.20, 73.74, 152.23 83.20, 52.50, 76.53
a, b, c () 90, 90, 90 90, 90, 90 90, 98.06, 90 90.0, 98.04, 90.0
Wavelength (Å) 0.9787 0.9787 0.9800 0.9800
Resolution (Å) 66.6–2.60 77.87–2.35 73.74–2.53 44.3–2.60
(2.68–2.60) (2.40–2.35) (2.60–2.53) (2.72–2.60)
Rsym 0.116 (0.646) 0.106 (0.715) 0.0755 (0.171) 0.036 (0.147)
I/r(I) 12.8 (3.6) 12.3 (2.2) 10.0 (5.1) 16.2 (4.4)
Completeness (%) 99.91 (99.64) 98.53 (89.55) 95.6 (91.3) 95.25 (78.35)
Redundancy 6.0 (5.1) 10.7 (6.0) 3.6 (3.5) 3.3 (2.7)
Reﬁnement
Resolution (Å) 77.87–2.35 73.28–2.53 44.3–2.6
No. reﬂections 68,894 52,051 9,270
Rwork/Rfree 0.236/0.264 0.257/0.286 0.206/0.286
No. atoms
Protein 8,284 8156 2134
Ligand/ion 0 0 5
Water 178 111 18
B-factors (Å2)
Protein 42.70 36.9 76.1
Ligand/ion – – 96.5
Water 34.60 23.2 59.8
R.m.s. deviations
Bond lengths (Å) 0.018 0.015 0.011
Bond angles () 1.81 1.66 1.52
Ramachandran plot
Most favoured (%) 96.47 98.17 96.70
Outliers (%) 0.00 0.00 1.10
Values in parenthesis are for the highest resolution shell.
Fig. 1. Architecture of the Borrelia periplasmic adaptor BesA. (A) Arrangement of 4 monomers in the P212121 crystal lattice. Chain A is coloured by domain in orange
(membrane proximal), yellow (b-barrel) and green (lipoyl). Dotted lines indicate the likely position of (unmodelled) residues 106–114 which have poorly deﬁned electron
density. (B) BesA monomer from the C2 space group. (C) The loop at the lipoyl domain tip represented as sticks with surrounding electron density (grey) contoured at 1r. For
this presentation the monomer is rotated 90 to (B).
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data-based assembly model of AcrAB-TolC [7] and the in vitro
co-crystal structure of an adaptor-transporter (CusBA) subcomplex
[35] tripartite pump assembly is facilitated by the ﬂexibility of the
adaptor’s serially-linked domains [11,13], which was conﬁrmed
byMDanalysis of the closely relatedMexA [36]. This ‘hinge’ ﬂexibil-
ity at the inter-domain linkers is also evident in the BesA variant
space groups which show movement of the lipoyl domain, relativeto the other domains (Fig. 3A). We further analysed BesA interdo-
main dynamics by performing a 23 ns MD simulation (Fig. 3B) of a
single monomer in aqueous solution. Two major motions are
observed ‘hinged’ at the interdomain linkers, i.e. independent
movement of both the lipoyl domain (Fig. 3B, left) and the MP
domain (Fig. 3B, right) relative to the b-barrel domain.
This conserved organisation, domain structure and inter-domain
ﬂexibility indicate a common adaptor function in proteobacteria
Fig. 2. Structural comparison of periplasmic adaptor proteins. BesA structure compared to known drug efﬂux pump adaptors MexA (P. aeruginosa) and AcrA (E. coli), MacA (E.
coli macrolide efﬂux pump) and the metal efﬂux pump adaptors CusB (E. coli) and ZneB (C. metallidurans). MP domains of BesA, MexA and AcrA have an N-terminal lipoyl
attachment site anchoring the adaptor in the IM. Dotted orange lines indicate unobserved MP domain terminal regions.
Fig. 3. Interdomain movement of BesA hinged at the ﬂexible linkers. Structures
were superposed over residues 60–71 and 150–229 (i.e. the b-barrel domain) using
superpose in the CCP4 suite. (A) Comparison of BesA monomers crystallised in C2
(blue) and P212121 (orange) space groups. Relative interdomain movement is
measured in degrees. Unmodelled loop residues are shown as dotted lines. (B)
Molecular dynamics (MD) simulation of BesA. The starting model (0 ns, grey from
P212121) is superposed to the main chain of snapshots from the MD trajectories at
12 ns (red) and 23 ns (green).
Fig. 4. Predicted assembly of the tripartite BesABC pump of B. burgdorferi. Left,
assembled E. coli TolC (red)-AcrA (coloured as in Fig. 2)-AcrB (blue) pump, based on
in vivo site-speciﬁc cross-linking and data-based multidomain docking [7]. Right,
predicted assembly of B. burgdorferi BesC (homology model, red)-BesA (coloured as
in Fig. 2)-BesB (homology model, blue), based on the E. coli model. The simplest
1:1:1 ratio of BesA-BesB-BesC is shown, based on AcrA-AcrB-TolC [7]. A 2:1:1 ratio
has also been suggested in which 6 adaptors form a ring round the transporter
mediated by contacts through the b-barrel and lipoyl domains, as seen in the
in vitro co-crystallised CusBA subcomplex [3,35,37]. The absence of an adaptor
a-hairpin in Borrelia BesA is not compensated by extra domains in the cognate IM
(BesB) or OM (BesC) pump components.
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therefore has signiﬁcant implications for tripartite efﬂux pump
assembly. Our data-basedmodel of the E. coli AcrAB-TolC pump sug-
gests the IM transporter and OM channel contact each other via their
juxtaposed apical a-helices, mediated by extensive interactions of
these two components with the four adaptor domains (Fig. 4, left)
[7]. Based on thismodel our predicted assembly of the Borrelia pump
indicates interaction between the exit duct and transporterwould be
essential to provide a continuous tunnel for substrate to bypass the
periplasm and exit the cell (Fig. 4, right). In this consistent view of
assembly the adaptor lipoyl domainwould bewell positioned to con-tact the exit duct (Fig. 4), as it would also be in the predicted HME
CusBAC assembly [35,37] in which the adaptor sits further up the
IM transporter than is calculated for drug efﬂux adaptors AcrA/MexA.
This suggests a key role for the lipoyl domain in the spirochete Be-
sABC pumpnot only in interactingwith the transporter TolC-docking
domains, as in the E. coli/Pseudomonas pumps [7], but also in stabilis-
ing TolC interaction. Otherwise, therewould be very little contact be-
tween adaptor and OM exit duct (Fig. 4, right). The BesA architecture
is incompatible with any model in which adaptor hairpins are sug-
gested to form homotypic interactions to create a tunnel that con-
tacts TolC tip-to-tip (Supplemental Fig. 1, left) [38], as in such a
model the predicted assembly is reliant on the hairpin to form a
sealed channel between separated IM and OM components
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left) is inconsistent with in vivo cross-linking data showing AcrB and
TolC interact [6,8], in vivo cross-linking that shows the full length of
the AcrA hairpin interacts with the periplasmic entrance of TolC
[7,15] and the CusBA crystal structure inwhich interactions between
CusB adaptors are mediated not through the a-hairpin domains but
through the b-barrel and lipoyl domains [3,35,37].
The high resolution structure of BesA establishes unequivocally
an important divergence from the paradigm adaptor structure. Pri-
mary sequences of other putative spirochete adaptors suggest the
BesA architecture may not be unique, as adaptor sequences lacking
the a-hairpin coding region can be identiﬁed in Borrelia, Treponema
and Spirochaeta (Supplemental Fig. 2). Indeed, comparable primary
sequences are also evident rarely in proteobacteria (e.g. Legionella).
This indicates that BesABC and most likely other similar pumps are
assembled without the extensive coiled-coil interactions shown to
be central to the otherwise closely related tripartite efﬂux pumps
of E. coli and P. aeruginosa. It is therefore possible that despite close
structural similarity among components different pumps require
distinct component interactions.
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